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Background
Hyperimmunoglobulin D Syndrome (HIDS is a rare
autosomal recessive condition caused by mutations in
the Mevalonate Kinase (MVK) gene that codes for
MVK, an essential enzyme in the isoprenoid pathway. It
shows a wide phenotypic spectrum probably related
with the residual activity of this enzyme (1–20% of nor-
mal). So far, about 63 mutations have been described
and the four most prevalent mutations account for
more than 70%.
Aim
Case report of a new mutation of the MVK gene in a
child with a severe Hyper-IgD syndrome.
Results
A 2-year-old portuguese boy presented with recurrent
episodes of fever and malaise, cervical lymphadenopathy
and hepatosplenomegaly since 12 months of age. Rash
was seen once. During acute attacks laboratory evalua-
tion demonstrated microcytic hypochromic anemia (Hg
8-10 g/dl), leukocytosis with neutrophilia (WBC 23 490-
32 280/mm
3) and increased ESR (61-91 mm/h), CRP
(6.27-18.49 mg/dl) and serum amyloid A (104-510 mg/
L). Clinical and laboratory improvement was seen
between attacks. Renal and liver functions, like cardiac
and ophthalmologic evaluations, were normal. Infectious
causes, primary immunodeficiency, neoplastic and auto-
immune diseases were excluded. Despite normal serum
IgD, HIDS was clinically suspected. DNA sequence ana-
lysis revealed a homozygous Arg-277-Gly (p.R277G)
new mutation in MVK gene. The healthy non-consan-
guineous parents were heterozygous for this mutation.
Short NSAIDs and corticosteroid courses were given
during attacks with poor benefits. Anakinra was started
(2mg/Kg/day), with partial clinical response.
Discussion
R277G is a previously unreported MVK mutation and in
this case was associated with a severe phenotype.
Further studies are needed to evaluate a co-relation gen-
otype-enzyme activity-phenotype and by so helping to
define best therapeutic strategies for each patient.
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